Key Differences Between AOD 9604 and MOTS-C | Feature | AOD 9604 | MOTS-C | |-----------------------|-------------------------------------|----------------------------------------| | Origin | HGH fragment | Mitochondrial peptide | | Primary function | Fat metabolism and fat loss | Cellular energy regulation and metabolism | | Effects on hormones | Minimal impact on HGH and insulin | Improves insulin sensitivity | | Common goals | Weight loss, fat reduction | Energy boost, metabolic health | | Research status | Several clinical trials on fat loss | Emerging research on metabolism | These differences mean the peptides serve different purposes, even though both relate to metabolism
No significant differences were found between the intervention and control groups at the end of study in serum myeloperoxidase, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, total oxidant capacity, or total oxidant capacity (Table 4)
The FDA has decided to move forward to consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of some of these peptides
Glutathione transferase from Trichoderma virens enhances cadmium tolerance without enhancing its accumulation in transgenic Nicotiana tabacum
Lipotropic B12 injections add vitamin B12, a nutrient that plays an important role in red blood cell formation, nervous system function, and DNA synthesis
